CHANGES IN SERUM IRON, TRANSFERRIN, AND FERRITIN LEVELS IN PATIENTS WITH NEPHROTIC SYNDROME AT LONG AN GENERAL HOSPITAL

Quang Thành Lê1, , Phương Nam Nguyễn1, Trần Tuấn Anh Nguyễn1, Đặng Lan Hương Bùi2, Tùng Hiệp Bùi3, Đặng Phương Chi Bùi3, Đặng Minh Trí Bùi3
1 Bệnh viện Đa khoa Long An
2 Bệnh viện Từ Dũ
3 Trường Đại học Y khoa Phạm Ngọc Thạch

Main Article Content

Abstract

Objective: To investigate serum iron, transferrin, and ferritin levels; to evaluate changes in these parameters after treatment; and to assess their associations with proteinuria and serum albumin in patients with nephrotic syndrome (NS).


Methods: This prospective longitudinal study included 64 adult patients with NS treated at Long An General Hospital between October 2024 and May 2026. Serum iron, transferrin, ferritin, and relevant clinical and biochemical parameters were assessed during the active phase of NS and reassessed after treatment in patients who achieved remission. Within-patient comparisons before and after treatment were performed using the paired Student’s t-test or Wilcoxon signed-rank test, as appropriate according to data distribution. Correlations were assessed using Pearson’s or Spearman’s correlation coefficients.


Results: The mean age was 47.8 ± 15.2 years, and 59.4% of patients were male. At baseline, the median 24-hour urinary protein excretion was 5.82 (4.31–7.46) g/24 h, and the mean serum albumin level was 22.6 ± 5.1 g/L. Mean serum iron and transferrin levels were 9.7 ± 4.1 µmol/L and 1.56 ± 0.42 g/L, respectively, while the median ferritin level was 286 (164–472) ng/mL. After treatment, 52 of 64 patients (81.3%) achieved remission. Among these patients, serum iron increased from 9.8 ± 4.0 to 15.1 ± 4.5 µmol/L and transferrin increased from 1.55 ± 0.41 to 2.24 ± 0.46 g/L (both p<0.001), whereas ferritin decreased from 281 (160–458) to 194 (112–306) ng/mL (p<0.001). The change in transferrin was positively correlated with the change in serum albumin (r=0.51; p<0.001) and inversely correlated with the change in proteinuria (r=−0.47; p<0.001).


Conclusion: Low serum transferrin was a common abnormality in patients with active NS. Among patients who achieved remission, serum iron and transferrin levels increased, whereas ferritin levels decreased from baseline. These changes were associated with concomitant changes in proteinuria and serum albumin.

Article Details

References

1. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4s):S1-s276.
2. Nakayama T, Azegami T, Yamaguchi S, Hirano K, Komatsu M, Fujii K, et al. Clinical relevance of proteinuria selectivity index and fractional excretion of sodium in patients with nephrotic syndrome. Sci Rep. 2024;14(1):23755.
3. Lê Văn An, Lê Chuyển, Dương Thị Ngọc Lan, Phạm Thị Thúy Vũ, Nguyễn Thị Thu Thảo, Võ Hoàng Lâm. Nghiên cứu nồng độ sắt, transferrin và ferritin huyết thanh ở bệnh nhân hội chứng thận hư tại Bệnh viện Trường Đại học Y - Dược Huế. . Tạp chí Y Dược học. 2021;11(6):70-6.
4. Xing Chen, Xiaoyu Liu, Zhen Feng, Zhijuan Hu, Kai Niu, Bing Liu. Clinical analysis of primary nephrotic syndrome complicating anemia. J Int Med Res. 2025;53(7):03000605251359458.
5. Tinna I, Vallabhaneni P, Dawman L, Bhatia P, Rawat A, Tiewsoh K. Iron deficiency and urine transferrin levels in pediatric steroid-resistant versus steroid- sensitive nephrotic syndrome: a cross-sectional comparative study. Egyptian Pediatric Association Gazette. 2025;73(1):132.
6. Yamamoto R, Isaka Y. Albumin Clearance as a Novel Predictor of Relapse in Adults with Minimal Change Nephrotic Syndrome. Kidney360. 2023;4(6):e720-e1. 10.34067/kid.0000000000000169
7. Ahmed SA, Hassouna A, Ibrahim HA, Sabry D, Abdelgwad M, Ali AY, Afifi N. Renal iron expression and urinary transferrin excretion in lupus nephritis: A case-control study. Lupus. 2025;34(13):1362-8.
8. Prinsen B, Velden M, Kaysen GA, Straver H, Rijn H, Stellaard F, et al. Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. J Am Soc Nephrol. 2001;12(5):1017-25.